Urology from 1989,and a specialist in Microsurgery and Experimental surgery from 1993.From May 1995 to February 2005,Prof.Siracusano served as the Assistant in Urology at the Urological Clinic,University of Trieste(Tr...
Inari M Ciccone,Elaine MF Costa,Juliana R Pariz,Thiago A Teixeira,Joel R Drevet,Parviz Gharagozloo,Robert J Aitken,Jorge Hallak.Serum vitamin D content is associated with semen parameters and serum testosterone levels...
Tis increased inthelastyearstobecome the second leading cause of death in males.!In this context,low-risk and intermediaterisk PCa are the most represented clinical patterns and undoubtedly most subjected to technolog...
In this nonsystematic review of the literature,we explored the changing landscape of detection and treatment of low-and intermediate-risk prostate cancer(PCa).Through emphasizing improved cancer assessment with histol...
This opinion focuses on the management of low-and intermediate-risk prostate cancer(PCa)groups,emphasizing the need for additional prognostic factors beyond existing risk categories.Molecular biology and multiparametr...
Prostate cancer is the second most common cancer in men;therefore,the development of adequate programs of prevention is essential to achieve an early detection of the disease and to reduce the mortality.Over the years...
Prostate cancer (PCa) is the second leading cause of cancer-related death among men. Prostate-specific antigen (PSA) testing is used in screening programs for early detection with a consequent reduction of PCa-specifi...
Prostate cancer risk stratification relies on several clinical factors. Low-risk patients, characterized by T1–T2a stage, Gleason score (GS) ≤6, and prostate-specific antigen (PSA) <10 ng ml−1, exhibit an excellent ...